The global botulinum toxin market size was valued at USD 8.14 billion in 2023 and is projected to grow from USD 8.74 billion in 2024 to USD 16.01 billion by 2032, exhibiting a CAGR of 7.9% during the forecast period (2024-2032). North America dominated the global botulinum toxin market, holding a market share of 66.34% in 2023. The global botulinum toxin market is highly competitive, centered on developing new products, forming partnerships, and expanding into new regions. Major botulinum toxin companies such as Allergan (AbbVie), Ipsen, and Medytox lead both the cosmetic and medical sectors, continuously improving their products and applications. Additionally, new entrants and research into innovative uses are helping to drive market growth. In terms of competition, there is an increasing trend of collaborations aimed at penetrating underdeveloped markets.
Read More>